Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
fda
4
×
indiana blog main
indiana top stories
keytruda
4
×
merck
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
bristol-myers squibb
life sciences
pembrolizumab
abeona therapeutics
affordable care act
agios pharmaceuticals
alirocuma
alzheimer's
ameet nathwani
arches
biotech
cancer
What
american
based
best
bio
cancer
continue
crash
debate
healthcare
industry
kind
nash
people
pharmaceutical
policy
politicians
pressure
roundup
scalps
trump’s
u.s
annual
approved
ash
barcelona
clinical
conference
december's
deeper
dna
drug
esmo
european
fda
fingerprint
genetic
going
kras
major
matter
Language
unset
Current search:
keytruda
×
fda
×
@xconomy.com
4 years ago
ESMO 2019: PARP and Prostate, SeaGen’s Win, KRAS Update & More
@xconomy.com
5 years ago
Bio Roundup: Trump’s Scalps, Policy Pressure, NASH Crash & More
@xconomy.com
5 years ago
Bio Roundup: Trump’s Scalps, Policy Pressure, NASH Crash & More
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues